FBXW7与原发性肝癌发生的关系
Relationship between FBXW7 and the Occurrence of Primary Liver Cancer
DOI: 10.12677/ACM.2021.113194, PDF,   
作者: 谭智勇:重庆市云阳县人民医院,重庆 云阳县;李春明, 龚建平:重庆医科大学附属第二医院肝胆外科,重庆
关键词: FBXW7原发性肝癌F-Box蛋白E3泛素连接酶分子靶向药物FBXW7 Primary Liver Cancer F-Box Proteins E3 Ubiquitin Ligases Molecular Targeting Drugs
摘要: SCF (SKP1-Cullin 1-F-box protein) E3泛素连接酶作为E3泛素连接酶中最重要的家族,负责人类机体内多种蛋白的降解。其中,F-box蛋白作为SCF E3泛素连接酶的底物受体,其功能失调在包括原发性肝癌在内的多种人类癌症中发挥着重要的作用。本文将根据国内外文献报道FBXW7在原发性肝癌发生发展中发挥的重要角色,为未来针对FBXW7及其信号通路的分子靶向药物的开发在原发性肝癌中的运用提供方向。
Abstract: As the most important family of E3 ubiquitin ligases, SCF (SKP1-Cullin1-F-box protein) E3 ubiquitin ligases are responsible for the degradation of a variety of proteins in the human body. Among all the components of SCF E3 ubiquitin ligases, aberrant regulation of the F-box protein plays an important role in a variety of human cancers, including primary liver cancer. In this paper, we will report the important role of FBXW7 in the occurrence and development of primary liver cancer according to domestic and foreign literatures. It also provides a direction for the exploitation of molecular targeting drugs of FBXW7 and its signaling pathway in the application of primary liver cancer in the future.
文章引用:谭智勇, 李春明, 龚建平. FBXW7与原发性肝癌发生的关系[J]. 临床医学进展, 2021, 11(3): 1362-1366. https://doi.org/10.12677/ACM.2021.113194

参考文献

[1] Dang, F., Nie, L. and Wei, W. (2021) Ubiquitin Signaling in Cell Cycle Control and Tumorigenesis. Cell Death and Differentiation, 28, 427-438. [Google Scholar] [CrossRef] [PubMed]
[2] Lauinger, L. and Kaiser, P. (2021) Sensing and Signaling of Methionine Metabolism. Metabolites, 11, 83. [Google Scholar] [CrossRef] [PubMed]
[3] Yumimoto, K. and Nakayama, K.I. (2020) Recent Insight into the Role of FBXW7 as a Tumor Suppressor. Seminars in Cancer Biology, 67, 1-15. [Google Scholar] [CrossRef] [PubMed]
[4] Huo, W., Qi, F. and Wang, K. (2020) Long Non-Coding RNA FER1L4 Inhibits Prostate Cancer Progression via Sponging miR-92a-3p and Upregulation of FBXW7. Cancer Cell International, 20, Article No. 64. [Google Scholar] [CrossRef] [PubMed]
[5] Yeh, C.H., Bellon, M. and Nicot, C. (2018) FBXW7: A Critical Tumor Suppressor of Human Cancers. Molecular Cancer, 17, Article No. 115. [Google Scholar] [CrossRef] [PubMed]
[6] Bogdanovic, A., Bulajic, P., Masulovic, D., et al. (2021) Liver Resection versus Transarterial Chemoembolization for Huge Hepatocellular Carcinoma: A Propensity Score Matched Analysis. Scientific Reports, 11, Article No. 4493. [Google Scholar] [CrossRef] [PubMed]
[7] Akinyemiju, T., Abera, S., Ahmed, M., et al. (2017) The Burden of Primary Liver Cancer and Underlying Etiologies from 1990 to 2015 at the Global, Regional, and National Level: Results from the Global Burden of Disease Study 2015. JAMA Oncology, 3, 1683-1691. [Google Scholar] [CrossRef] [PubMed]
[8] Wang, D., Pierce, A., Veo, B., et al. (2021) A Regulatory Loop of FBXW7-MYC-PLK1 Controls Tumorigenesis of MYC-Driven Medulloblastoma. Cancers, 13, 387. [Google Scholar] [CrossRef] [PubMed]
[9] Zhong, L., Zhang, Y., Li, M., et al. (2020) E3 Ligase FBXW7 Restricts M2-Like Tumor-Associated Macrophage Polarization by Targeting c-Myc. Aging, 12, 24394-24423. [Google Scholar] [CrossRef] [PubMed]
[10] Hynes-Smith, R.W., Wittorf, K.J. and Buckley, S.M. (2020) Regulation of Normal and Malignant Hematopoiesis by FBOX Ubiquitin E3 Ligases. Trends in Immunology, 41, 1128-1140. [Google Scholar] [CrossRef] [PubMed]
[11] Li, K., Wang, F., Yang, Z.N., et al. (2020) TRIB3 Promotes MYC-Associated Lymphoma Development through Suppression of UBE3B-Mediated MYC Degradation. Nature Communications, 11, Article No. 6316. [Google Scholar] [CrossRef] [PubMed]
[12] Zhang, Q., Li, X., Cui, K., et al. (2020) The MAP3K13-TRIM25-FBXW7α Axis Affects c-Myc Protein Stability and Tumor Development. Cell Death and Differentiation, 27, 420-433. [Google Scholar] [CrossRef] [PubMed]
[13] Wu, W.J., Shi, J., Hu, G., et al. (2016) Wnt/Β-Catenin Signaling Inhibits FBXW7 Expression by Upregulation of microRNA-770 in Hepatocellular Carcinoma. Tumour Biology, 37, 6045-6051. [Google Scholar] [CrossRef] [PubMed]
[14] Wang, Y., Liu, Z., Yao, B., et al. (2017) Long Non-Coding RNA CASC2 Suppresses Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells through CASC2/miR-367/FBXW7 Axis. Molecular Cancer, 16, Article No. 123. [Google Scholar] [CrossRef] [PubMed]
[15] Tang, B., Lei, B., Qi, G., et al. (2016) MicroRNA-155-3p Promotes Hepatocellular Carcinoma Formation by Suppressing FBXW7 Expression. Journal of Experimental & Clinical Cancer Research, 35, Article No. 93. [Google Scholar] [CrossRef] [PubMed]
[16] Tang, X., Yang, W., Shu, Z., et al. (2019) MicroRNA-223 Promotes Hepatocellular Carcinoma Cell Resistance to Sorafenib by Targeting FBW7. Oncology Reports, 41, 1231-1237. [Google Scholar] [CrossRef] [PubMed]
[17] Deng, P. and Wu, Y. (2019) Knockdown of miR-106a Suppresses Migration and Invasion and Enhances Radiosensitivity of Hepatocellular Carcinoma Cells by Upregulating FBXW7. International Journal of Clinical and Experimental Pathology, 12, 1184-1193.
[18] Zhu, Z.Z., Bao, L.L., Zhao, K., et al. (2019) Copy Number Aberrations of Multiple Genes Identified as Prognostic Markers for Extrahepatic Metastasis-Free Survival of Patients with Hepatocellular Carcinoma. Current Medical Science, 39, 759-765. [Google Scholar] [CrossRef] [PubMed]
[19] Tu, K., Yang, W., Li, C., et al. (2014) FBXW7 Is an Independent Prognostic Marker and Induces Apoptosis and Growth Arrest by Regulating Yap Abundance in Hepatocellular Carcinoma. Molecular Cancer, 13, Article No. 110. [Google Scholar] [CrossRef] [PubMed]
[20] Wang, X., Zhang, J., Zhou, L., et al. (2015) FBXW7 Regulates Hepatocellular Carcinoma Migration and Invasion via Notch1 Signaling Pathway. International Journal of Oncology, 47, 231-243. [Google Scholar] [CrossRef] [PubMed]
[21] Tu, K., Zheng, X., Zan, X., et al. (2012) Evaluation of FBXW7 Expression and Its Correlation with the Expression of c-Myc, Cyclin E and p53 in Human Hepatocellular Carcinoma. Hepatology Research, 42, 904-910. [Google Scholar] [CrossRef